The NMC rule mandating generic name prescriptions aims to reduce out-of-pocket costs by promoting competition, but its implementation is delayed due to legitimate concerns over quality control in our drug supply chain. Substitution at the pharmacy means the chemist can replace a prescribed branded drug with a generic equivalent, which saves money but hinges on trust in the chemist's choice. From my research, the obvious push for savings overlooks a critical market failure: without robust quality assurance, forced substitution risks health for mere price competition. Watching my own father hesitate between a cheaper generic and a trusted brand for his blood pressure, despite the cost burden, perfectly illustrates this crisis of confidence that policymakers underestimate.
#health#hospitals
Jump in to reply — no account needed.